
Should You Take Hormone Replacement Therapy (HRT)?
We created a tool to help you sift through the noise.
Spend five minutes in any menopause group online and you'll see the same scene: a woman with confusing symptoms, a chorus telling her to "just get on hormones," and plenty of confident claims on every side. We see it as a more individual decision. As clinicians specializing in perimenopause and menopause, we have watched HRT (which The Menopause Society calls Menopausal Hormone Therapy, or MHT) help many women feel like themselves again, and we've seen it be the wrong fit for others. The difference usually comes down to your symptoms, your personal and family history and risk profile, and, for some women, factors like lifetime estrogen exposure and how their body processes estrogen. Hormones are a tool, not a cure-all, and they're one of several ways through this transition. This tool won't hand you a prescription or a verdict. It will help you weigh the risks and benefits so you can make an informed decision, your decision, with a clinician who treats you as an individual, not a population average.
Avra Health provides integrative, root-cause perimenopause and menopause care in person in Longmont, Colorado, and by virtual visit to residents of Colorado, Arizona and Washington.
Menopause is normal — and MHT (HRT) isn't the only road through it
The menopausal transition is a normal part of life, and not every woman needs hormones to feel well. For moderate-to-severe hot flashes, vaginal changes, and bone protection, hormone therapy is genuinely effective, and for many women who begin under 60 or within about ten years of menopause it's reasonable to consider. But somewhere along the way, "a helpful tool for some women" turned into "everyone should be on hormones" — and that's where I part ways with the loudest voices online. Whether Menopausal Hormone Therapy (also known as Hormone Replacement Therapy) is right for you depends on your whole picture, and there are effective, evidence-based alternatives for nearly every symptom.
A clinical lens: your lifetime estrogen exposure
Estrogen does a lot of good. It supports your heart, bones, brain, mood, sleep, skin and joints. In our practice, we also find it helpful to think about estrogen exposure over a lifetime. Picture it as the area under a curve that rises in puberty, cycles through your reproductive years and drops in menopause. Some markers of longer lifetime exposure, such as an earlier first period or a later menopause, are associated with a modestly higher risk of breast cancer. Whether that idea applies to hormone therapy for an individual woman hasn't been directly tested in research; it's a framework built on indirect evidence and clinical experience. We use it as one input in an individual conversation about your risks and benefits, not as a reason to avoid hormones.
The different roads of estrogen — an emerging area
Your body doesn't just make estrogen; it also has to break it down and clear it, and it can do that along more than one pathway. The 2-OH pathway is generally considered the gentler route. The 4-OH pathway can form reactive compounds that, in laboratory studies, can damage DNA, and some research has linked it to breast cancer risk. Which pathway your body favors may be influenced by genes such as CYP1A1 and CYP1B1, while CYP3A4 and COMT play a role in how quickly estrogen is cleared. This research is still emerging and isn't part of standard guidelines, but some women find it useful context. If you'd like more information before deciding about HRT, we offer optional testing of these estrogen-metabolism genes.
What this tool weighs
This tool walks through factors that matter in this decision: your age and where you are in the transition; which symptoms are bothering you, and how well MHT helps each one (some more than others); your personal and family history; and a plain-language primer on the estrogen-metabolism genes above. It also surfaces evidence-based, non-hormonal options for every symptom, because for many women those are a reasonable first step. It won't score you or hand you a verdict — it gives you a balanced, personalized summary to talk through with a clinician.
The honest points most quizzes skip
A few things this tool won't gloss over. Hormone therapy protects bone while you take it; after stopping, that benefit fades over a few years, so it's usually one part of a long-term bone plan rather than the whole plan (though treating active bone loss can be appropriate). MHT isn't a weight-loss treatment, and menopausal weight changes are influenced by many factors, including muscle loss, cortisol, blood sugar, inflammation and sleep. For symptoms like brain fog, joint pain and low libido, hormones can play a role, and so can inflammation, stress and poor sleep, so it's worth looking at the whole picture. Route matters, too: for women with certain clotting risks, oral estrogen may not be appropriate, and a patch or gel may be an option to discuss with your clinician.
There are real alternatives
If you'd rather not start hormones — or you're not a good candidate — you have options, and good ones. Non-hormonal medications (including the newer NKB-blockers for hot flashes), well-studied herbs and nutraceuticals, and targeted lifestyle work aimed at the root cause — cortisol, blood sugar, inflammation, thyroid, sleep — carry many women comfortably through this transition. The right plan depends on you, which is where a root-cause, naturopathic approach earns its keep.
Talk it through — the Avra Health way
This guide is a starting point, not a decision. Before we build any hormone plan, we look at your whole picture: your history, symptoms, goals and risks. "First, do no harm" means understanding your individual risk before adding estrogen, not after.
At in-person visits in Longmont, we also measure your body composition with bioelectrical impedance analysis (BIA) and your heart rate variability (HRV) with NervExpress, at your first visit and at follow-ups. BIA shows your structure (muscle, fat and fluid balance); HRV shows your adaptive capacity, or how well your nervous system is handling stress. We look at both before recommending supplements, medication or hormones. That's what sets us apart from a clinic that prescribes hormones to everyone: we work on the root cause, and use hormone therapy (MHT) when it's appropriate for you and when it's what you want.
If you have concerns about HRT and want more information, genetic testing is an option. Your estrogen-metabolism genes can show how your body processes estrogen. It's optional, not required. If you'd like a clinician to weigh your history and risks with you and map out the right approach, hormonal or not, you can book your first visit online.

About the Author
Avra Health was founded by Dr. April Graham, ND, a naturopathic doctor focused on integrative, root-cause perimenopause and menopause care. Taking a calm, collaborative approach, I help you understand what's driving your symptoms and develop practical strategies for your well-being, with hormones or without. Together, we'll create a tailored path to health that empowers you to make informed choices.
This is for education and information only — it isn't medical advice, and it doesn't create a doctor–patient relationship. Please talk with your healthcare provider before making any changes to your health plan.
HRT FAQs
It depends on the type of therapy and on you. In the largest trial, the Women's Health Initiative, estrogen plus progestin was linked to a small increase in breast cancer risk after several years of use, while estrogen alone (in women without a uterus) was not, and was associated with fewer breast cancers. Your personal and family history matter most. Some clinicians, including us, also consider lifetime estrogen exposure and how your body processes estrogen. These are less directly studied, but they can help guide an individual conversation about whether MHT is a good fit for you.
For many women, yes; for others, no. If you're under 60 or within about ten years of menopause with bothersome hot flashes or vaginal symptoms, MHT can be a reasonable option. It's an individual decision based on your symptoms and your personal and family history, and some women also want to factor in things like lifetime estrogen exposure or genetics. There are effective alternatives for most symptoms, too. This tool helps you weigh your own picture.
Not at all. Menopause is a normal transition, and many women do beautifully without hormones. There are effective, evidence-based alternatives for the main symptoms — non-hormonal medications, well-studied herbs and nutraceuticals, and root-cause lifestyle work on sleep, stress and cortisol, blood sugar, and inflammation. For many women, those are a good first step or a complete plan on their own.
For clot and stroke risk, transdermal estrogen (a patch or gel) is believed to be generally safer than pills, because it largely avoids the clot-promoting effect that oral estrogen has - however, the evidence is limited. Which is right for you depends on your risk factors — a conversation to have with your clinician.
Your genetics can't give a yes-or-no, but they can add context to your risk profile. Enzymes like CYP1A1, CYP1B1, CYP3A4 and COMT may influence which pathway your body uses to break down estrogen and how quickly you clear it. This is an emerging area of research and isn't part of standard guidelines, so it belongs with a clinician who can interpret it alongside your history, not an automated at-home readout.
MHT is not a weight-loss treatment. The best study showed only a very modest effect, around 1.4 pounds over five years. Menopausal weight changes are influenced by many factors, including muscle loss, cortisol, blood sugar, inflammation and sleep, and that's where we focus.
No — and this is a common misunderstanding. About 85% of breast cancers occur in women with no family history, largely from genetic changes that accumulate with age and environmental exposures. A clean family tree isn't full reassurance, and a family history doesn't automatically rule MHT out. It's one piece of a larger, individual picture.